The research areas identified in this document rely on a wide range of research tools and approaches, spanning disciplines across the sciences and social sciences. This section is not an exhaustive list of the tools and approaches of interest to Defra. It identifies some areas of particular relevance and change, which will be important in addressing the challenges faced by Defra and represented throughout this document.
Societies demand resource from the environment and shape that environment. The social science of human-nature interactions is of fundamental importance to Defra.
Get in touch with ari.comment@go-science.gov.uk
This question was published as part of the set of ARIs in this document:
Pathogens in their livestock, wildlife and environmental hosts exert a constant pressure on the human population. Coupled with their evolution and adaptation, the matter is not so much whether a new epidemic will emerge,...
Funded by: MRC
Lead research organisation: University of Stirling
The project focuses on understanding and controlling the ways pathogens emerge and spread, which is relevant to the question about public acceptability of disease measures.
In order to make informed strategy for the good of UK citizens and to implement it through well-founded and informed policy, the policy-makers need evidence. They need to know what is known in an area and what has yet to...
Funded by: NERC
Lead research organisation: NERC CEH (Up to 30.11.2019)
The project explores the effectiveness of nature-based solutions and their co-benefits and co-harms, which is partially relevant to the question about public acceptability of disease measures.
What is the main aim? It is to bring businesses, scientists and health professionals together to share their knowledge, and to form a new project partnership. That project will simultaneously provide new insights in the...
Funded by: NERC
Lead research organisation: UNIVERSITY OF EXETER
The project focuses on the health benefits of engaging with nature and the ecological impacts of increasing green prescriptions, which is partially relevant to the question about public acceptability of disease measures.